Genome editing abrogates angiogenesis in vivo

Genome editing abrogates angiogenesis in vivo

Angiogenesis, in which vascular endothelial growth factor receptor (VEGFR) 2 plays an essential role, is associated with a variety of human diseases including proliferative diabetic retinopathy and wet age-related macular degeneration. Here we report that a system of adeno-associated virus (AAV)-med...

Full description

Bibliographic Details
Main Authors:	Huang, Xionggao, Zhou, Guohong, Wu, Wenyi, Duan, Yajian, Ma, Gaoen, Song, Jingyuan, Xiao, Ru, Vandenberghe, Luk, Zhang, Feng, D’Amore, Patricia A., Lei, Hetian
Other Authors:	Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Format:	Article
Published:	Nature Publishing Group 2017
Online Access:	http://hdl.handle.net/1721.1/112302 https://orcid.org/0000-0003-2782-2509

Similar Items

The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created
by: Duan, Yajian, et al.
Published: (2018)

In vivo genome editing using Staphylococcus aureus Cas9
by: Ran, F. Ann, et al.
Published: (2016)

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
by: Taylor, Martin S., et al.
Published: (2018)

Abrogation of oncogenic k-ras function by andrographolide derivatives via in silico, in vitro, and in vivo approaches
by: Quah, Shun Ying
Published: (2021)

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
by: Wang, D, et al.
Published: (2021)

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
by: Wang, Dan, et al.
Published: (2022)

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
by: Nelson, C. E., et al.
Published: (2017)

Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
by: Wei, Tuo, et al.
Published: (2022)

Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
by: Wei, Tuo, et al.
Published: (2021)

In vivo gene editing in dystrophic mouse muscle and muscle stem cells
by: Tabebordbar, M., et al.
Published: (2017)

Towards in vivo editing of the human microbiome
by: Yaung, Stephanie J. (Stephanie Jinyu)
Published: (2015)

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
by: Yin, Hao, et al.
Published: (2019)

An overview of in vitro, in vivo, and computational techniques for cancer-associated angiogenesis studies
by: Rahman, Heshu Sulaiman, et al.
Published: (2020)

Characterization and Engineering of Transposons for Genome Editing
by: Ladha, Alim
Published: (2023)

Editing DNA Methylation in the Mammalian Genome
by: Liu, X. Shawn, et al.
Published: (2018)

Therapeutic genome editing: prospects and challenges
by: Cox, David Benjamin Turitz, et al.
Published: (2016)

Applications of genome editing for disease modeling in mice
by: Platt, Randall Jeffrey
Published: (2016)

The NIH Somatic Cell Genome Editing program
Published: (2021)

Precise and expansive genomic positioning for CRISPR edits
by: Jakimo, Noah Michael.
Published: (2020)

The NIH Somatic Cell Genome Editing program
by: Anderson, Daniel Griffith, et al.
Published: (2022)

Engineering and optimising deaminase fusions for genome editing
by: Yang, Luhan, et al.
Published: (2017)

Efficient genome editing in plants using a CRISPR/Cas system
by: Feng, Zhengyan, et al.
Published: (2016)

Induced Pluripotent Stem Cells Meet Genome Editing
by: Hockemeyer, Dirk, et al.
Published: (2018)

Exploration of methods for many-site genome editing with MAGE
by: Sterling, Bram (Bram H.)
Published: (2012)

Stem Cells, Genome Editing, and the Path to Translational Medicine
by: Soldner, Frank, et al.
Published: (2020)

Development of CRISPR-Cas systems for genome editing and beyond
by: Zhang, F.
Published: (2022)

Genome Editing Technologies: Defining a Path to Clinic
by: Corrigan-Curay, Jacqueline, et al.
Published: (2017)

Development of CRISPR-Cas systems for genome editing and beyond
by: Zhang, F
Published: (2021)

Mechanical loading response in trabecular bone is abrogated by sclerostin - A direct demonstration
by: Khalid, Kamarul Ariffin, et al.
Published: (2012)

Tick resistance. Abrogation of the immune response to Boophilus microplus by systemic injections of cortisone
by: Babjee, Shaik Mohamed Amin, et al.
Published: (1986)

Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function
by: Hocker, Harrison J., et al.
Published: (2013)

Allocating and abrogating rights : how could conflicts be resolved under incomplete information?
by: Farrell, Joseph
Published: (2011)

Building Capacity for a Global Genome Editing Observatory: Institutional Design
by: Saha, Krishanu, et al.
Published: (2020)

Building Capacity for a Global Genome Editing Observatory: Conceptual Challenges
by: Hurlbut, J. Benjamin, et al.
Published: (2020)

Genome editing in mammalian cell lines using CRISPR-Cas
by: Liu, Ivy Kaiwen, et al.
Published: (2021)

Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
by: Qiu, M, et al.
Published: (2021)

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo
by: Chung, I., et al.
Published: (2009)

Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells
by: Torres-Ruesta, Anthony, et al.
Published: (2023)

FUT6 deficiency compromises basophil function by selectively abrogating their sialyl-Lewis x expression
by: Puan, Kia Joo, et al.
Published: (2022)

Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
by: Papathanasiou, Stamatis, et al.
Published: (2022)